Cite

HARVARD Citation

    Sun, W. et al. (2018). A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses. Cellular & molecular immunology. 15 (8), pp. 768-781. [Online]. 
  
Back to record